News

GlaxoSmithKline Pharmaceuticals is a subsidiary of the GSK Group in India. Its objective is to get ahead of disease with the ...
DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...
As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...
A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to ...
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...
GSK has shifted towards a global marketing ... While the new CEO has made some high-profile changes to the company’s management team, there have been some changes to the way the company ...
reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE: GSK) for violations of §§10(b) ...
For example, in Florida, a federal judge dismissed about 50,000 lawsuits against the company. Last month, in the first case to go before a jury, GSK and one of its peers won a case in Illinois.
The firm owned 17,050 shares of the pharmaceutical company’s stock after buying an additional 1,964 shares during the period. Independent Advisor Alliance’s holdings in GSK were worth $577,000 ...